$20.84▴ 6.87%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Schrodinger, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days2 articles
2 bullish0 neutral0 bearish
Global Drug Discovery AI Tools Market - Strategic Forecast 2026-2032 | Generative AI, Cloud Platforms, and Integrated R&D Workflows Create New Growth Opportunities
Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and Development
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It